20724 Federal Register / Vol. 60, No. 81 / Thursday, April 27, 1995 / Notices

Study section/contact person May–July 1995

meetings Time Location

Experimental Therapeutics-1, Dr. Philip Perkins, 301–594–

7324.

June 14–16 ............ 8:30 a.m. ........... Hyatt Hotel, Arlington, VA.

Experimental Therapeutics–2, Dr. Marcia Litwack, 301–

594–7366.

June 28–30 ............ 8:30 a.m ............ Holiday Inn Crowne Plaza, Rockville, MD.

Metabolic Pathology, Dr. Marcelina Powers, 301–594–

7120.

June 27–29 ............ 8:30 a.m ............ Holiday Inn, Chevy Chase, MD.

Pathology A, Dr. Larry Pinkus, 301–594–7315 ................... June 6–8 ................ 7:00 p.m ............ Quality Hotel Capitol Hill, Washington,

DC.

Pathology B, Dr. Martin Padarathsingh, 301–594–7192 ..... June 7–9 ................ 8:00 a.m ............ Holiday Inn, Georgetown, DC.

Radiation, Dr. Paul Strudler, 301–594–7152 ....................... June 5–7 ................ 8:30 a.m ............ Embassy Suites Hotel, Chevy Chase Pavilion, Washington, DC.

Pathophysiological Sciences Initial Review Group

Lung Biology & Pathology, Dr. Anne Clark, 301–594–7115 June 14–16 ............ 8:00 a.m ............ Holiday Inn, Chevy Chase, MD.

Physiology, Dr. Michael Lang, 301–594–7332 .................... June 14–16 ............ 8:30 a.m ............ Embassy Suites Hotel, Chevy Chase Pavilion, Washington, DC.

Respiratory & Applied Physiology, Dr. Everett Sinnett,

301–594–7220.

June 7–9 ................ 8:30 a.m ............ One Washington Circle Hotel, Washington, DC.

Sensory Sciences Initial Review Group

Hearing Research, Dr. Joseph Kimm, 301–594–7257 ........ June 12–14 ............ 8:30 a.m ............ Radisson Barcelo Hotel, Washington, DC.

Sensory Disorders & Language, Dr. Jane Hu, 301–594–

7269.

June 14–16 ............ 8:30 a.m ............ Holiday Inn, Capitol Hill, Washington, DC.

Visual Sciences A, Dr. Luigi Giacometti, 301–594–7132 .... June 14–16 ............ 8:30 a.m ............ Holiday Inn Crowne Plaza, Rockville, MD.

Visual Sciences B, Dr. Leonard Jakubczak, 301–594–

7198.

June 7–9 ................ 8:30 a.m ............ The Latham Hotel, Washington, DC.

Visual Sciences C, Dr. Carole Jelsema, 301–594–7311 .... June 14–16 ............ 8:00 a.m ............ The Georgetown Inn, Washington, DC.

Surgery, Radiology and Bioengineering Initial Review Group

Diagnostic Radiology, Dr. Catharine Wingate, 301–594–

7295.

June 5–7 ................ 8:30 a.m ............ Hotel Washington, Washington, DC.

Surgery & Bioengineering, Dr. Paul Parakkal, 301–594–

7258.

June 8–9 ................ 8:00 a.m. ........... The Georgetown Inn, Washington, DC.

Surgery, Anesthesiology & Trauma, Dr. Richard Panniers,

301–594–7348.

June 21–23 ............ 2:00 p.m ............ Holiday Inn, Bethesda, MD.

The meetings will be closed in

accordance with the provisions set forth

in sec. 552b(c)(4) and 552b(c)(6), Title 5,

U.S.C. Applications and/or proposals

and the discussions could reveal

confidential trade secrets or commercial

property as patentable material and

personal information concerning

individuals associated with the

applications and/or proposals, the

disclosure of which would constitute a

clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. 93.306, 93.333, 93.337, 93.393–

93.396, 93.837–93.844, 93.846–93.878,

93.892, 93.893, National Institutes of Health,

HHS)

Dated: April 21, 1995.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 95–10371 Filed 4–26–95; 8:45 am]

BILLING CODE 4140–01–M

National Cancer Institute; Notice of

Meetings of the National Cancer

Advisory Board and its Subcommittees

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the

National Cancer Advisory Board,

National Cancer Institute, and its

Subcommittees on May 15–17, 1995.

Except as noted below, the meetings of

the Board and its Subcommittees will be

open to the public to discuss issues

relating to committee business as

indicated in the notice. Attendance by

the public will be limited to space

available.

A portion of the Board meeting will

be closed to the public in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

and sec. 10(d) of Pub. L. 92–463, for the

review, discussion and evaluation of

individual grant applications and for

discussion of issues pertaining to

programmatic areas and/or NCI

personnel. These applications and

discussions could reveal confidential

trade secrets or commercial property

such as patentable material, and

personal information concerning the

individuals associated with the

applications or programs, the disclosure

of which would constitute a clearly

unwarranted invasion of personal

privacy.

The Committee Management Office,

National Cancer Institute, National

Institutes of Health, Executive Plaza

North, Room 630, 9000 Rockville Pike,

Bethesda, Maryland 20892 (301/496–

5708), will provide summaries of the

meetings and rosters of the Board

members, upon request.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact Ms. Carole Frank, Committee

Management Specialist, at 301/496–

5708 in advance of the meeting.

Name of Committee: Subcommittee on

Cancer Centers.

Contact Person: Dr. Brian Kimes, Executive

Secretary, National Cancer Institute, NIH,

Executive Plaza North, Room 3000, 6130

Executive Blvd., Bethesda, MD 20892–7094;

(301) 496–8537.
Federal Register / Vol. 60, No. 81 / Thursday, April 27, 1995 / Notices 20725

Date of Meeting: May 15, 1995.

Place of Meeting: Bethesda Marriott, 5151

Pooks Hill Road, Bethesda, MD.

Open: 5 pm to 7 pm.

Agenda: To discuss the cancer centers.

Name of Committee: Subcommittee on

Information and Cancer Control.

Contact Person: Mr. Paul Van Nevel,

Executive Secretary, National Cancer

Institute, NIH, Building 31, Room 10A31,

9000 Rockville Pike, Bethesda, MD 20892;

(301) 496–6631.

Date of Meeting: May 15, 1995.

Place of Meeting: Bethesda Marriot, 5151

Pooks Hill Road, Bethesda, MD 20814.

Open: 7 pm to 8:30 pm.

Agenda: To discuss cancer control issues.

Name of Committee: National Cancer

Advisory Board.

Contact Person: Dr. Marvin R. Kalt,

Executive Secretary, National Cancer

Institute, NIH, Executive Plaza North, Room

600A, 6130 Executive Blvd., Bethesda, MD

20892–7405; (301) 496–5147.

Dates of Meeting: May 16–17, 1995.

Place of Meeting: Conference Room 10, C

Wing Building 31, National Institutes of

Health, 9000 Rockville Pike, Bethesda, MD

20892.

Open: May 16—8 am to approximately 5

pm.

Agenda: Report on activities of the

President’s Cancer Panel; the Acting

Director’s Report on the National Cancer

Institute; Effects of Third Party Payment on

Clinical Research; Cancer Centers; and the

NCAB AD HOC Working Group on the NCI

Intramural Programs.

Closed: May 17—8 am to approximately

9:45 am.

Agenda: For review and discussion of

individual grant applications and

extramural/intramural programmatic and

personnel policies.

Open: May 17—9:45 am to adjournment.

Agenda: Subcommittee Reports and

Continuing New Business.

Name of Committee: Subcommittee on

Basic and Environmental Sciences.

Contact Person: Dr. Susan Sieber,

Executive Secretary, National Cancer

Institute, NIH, Building 31, Room 11A03,

9000 Rockville Pike, Bethesda, MD 20892;

(301) 496–5946.

Date of Meeting: May 16, 1995.

Place of Meeting: Building 31C, Conference

Room 9, National Institutes of Health, 9000

Rockville Pike, Bethesda, MD.

Open: 12:30 pm to 1:15 pm.

Agenda: To discuss basic and

environmental sciences issues.

Name of Committee: Subcommittee for

Special Priorities.

Contact Person: Ms. Irish Schneider,

Executive Secretary, National Cancer

Institute, NIH, Building 31, Room 11A48,

Bethesda, MD 20892; (301) 496–5534.

Date of Meeting: May 16, 1995.

Place of Meeting: Building 31C, Conference

Room 7, National Institutes of Health, 9000

Rockville Pike, Bethesda, MD.

Open: 12:30 pm to 1:45 pm.

Agenda: To discuss issues related to

special priorities.

Name of Committee: Subcommittee on

Planning and Budget.

Contact Person: Ms. Cherie Nichols,

Executive Secretary, National Cancer

Institute, NIH, Building 31, Room 11A19,

Bethesda, MD 20892; (301) 496–5515.

Date of Meeting: May 16, 1995.

Place of Meeting: Building 31C, Conference

Room 7, National Institutes of Health, 9000

Rockville Pike, Bethesda, MD 20892.

Open: Immediately following adjournment

of full Board meeting.

Agenda: To discuss the NCI budget and

various planning issues.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.393, Cancer Cause and

Prevention Research; 93.394, Cancer

Detection and Diagnosis Research, 93.395,

Cancer Treatment Research; 93.396, Cancer

Biology Research; 93.397, Cancer Centers

Support; 93.398, Cancer Research Manpower;

93.399, Cancer Control.)

Dated: April 21, 1995.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 95–10374 Filed 4–26–95; 8:45 am]

BILLING CODE 4140–01–M

National Institute on Aging; Notice of

Meeting of the Board of Scientific

Counselors

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the Board

of Scientific Counselors, National

Institute on Aging, May 22–23, 1995, to

be held at the Gerontology Research

Center, Baltimore, Maryland. The

meeting will be open to the public from

9:30 a.m. to 12:30 p.m. and from 1:30 to

5:30 p.m. on Monday, May 22; and from

9:30 a.m. to 12:30 p.m. and from 1:30 to

3:30 p.m. on Tuesday, May 23.

Attendance by the public will be limited

to space available.

In accordance with the provisions set

forth in sec. 552b(c)(6), Title 5, U.S.C.

and sec. 10(d) of Pub. L. 92–463, the

meeting will be closed to the public on

May 22 from 8:30 to 9:30 a.m.; 12:30 to

1:30 p.m.; and from 5:30 to 6:30 p.m.;

and on May 23 from 8:30 to 9:30 a.m.;

from 12:30 to 1:30 p.m.; and from 3:30

p.m. to adjournment for the review,

discussion, and evaluation of individual

programs and projects conducted by the

National Institute on Aging, NIH,

including consideration of personnel

qualifications and performance, and the

competence of individual investigators,

the disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

Ms. June C. McCann, Committee

Management Officer, NIA, Gateway

Building, Room 2C218, National

Institutes of Health, Bethesda, Maryland

20892, (301/496–9322), will provide a

summary of the meeting and a roster of

committee members upon request.

Dr. Edward Lakatta, Acting Scientific

Director, NIA, Gerontology Research

Center, 4940 Eastern Avenue, Baltimore,

Maryland 21224, will furnish

substantive program information.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact the Scientific Director in

advance of the meeting.

(Catalog of Federal Domestic Assistance

Program No. 93.866, Aging Research,

National Institutes of Health)

Dated: April 21, 1995.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 95–10375 Filed 4–26–95; 8:45 am]

BILLING CODE 4140–01–M

National Cancer Institute; Notice of

Cancellation of Meeting

Notice is hereby given of the

cancellation of the meeting of the

Acrylonitrile Study Advisory Panel,

National Cancer Institute, May 3, 1995,

6130 Executive Boulevard, Room 418,

Rockville, Maryland, which was

published in the Federal Register on

March 17 (60 FR 14439).

The meeting is being canceled

because current pending issues were

resolved at the March meeting of this

Panel and it was decided an additional

meeting at this time is not necessary.

Dated: April 20, 1995.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 95–10376 Filed 4–26–95; 8:45 am]

BILLING CODE 4140–01–M

Division of Research Grants; Notice of

Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Division

of Research Grants Special Emphasis

Panel (SEP) meetings:

Purpose/Agenda: To review individual

grant applications.

Name of SEP: Behavioral and

Neurosciences.

Date: May 12, 1995.

Time: 2 p.m.

Place: NIH, Westwood Building, Room

325C, Telephone Conference.

Contact Person: Dr. Leonard Jakubczak,

Scientific Review Admin., 5333 Westbard

Ave., Room 325C, Bethesda, MD 20892, (301)

594–7198.

Name of SEP: Clinical Sciences.

Date: June 16, 1995.

Time: 8:30 a.m.

Place: American Inn, Bethesda, MD.

Contact Person: Dr. Joseph Kaiser,

Scientific Review Admin., 6701 Rockledge